TuHURA BIOSCIENCES, INC./NV Accounts Payable and Accrued Liabilities, Current
TuHURA BIOSCIENCES, INC./NV (HURA) had Accounts Payable and Accrued Liabilities, Current of $3.87 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $3.87M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $5.86M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $5.72M; Accounts Payable and Accrued Liabilities, Current as first filed $5.52M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $5.48M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.87M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $5.86M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.72M 10-Q · filed 2026-08-14 | $5.52M 10-K · filed 2026-03-31 |
| 2025-09-30 | $5.48M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $12.09M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.62M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $5.17M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.21M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.21M 10-Q · filed 2024-11-14 | |
| 2024-03-31 | $1.24M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.44M 10-K · filed 2025-03-31 | $1.72M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $3.00M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.78M 10-K · filed 2024-10-07 | |
| 2023-03-31 | $2.61M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.69M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $2.94M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.27M 10-K · filed 2023-09-18 | |
| 2022-03-31 | $2.78M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.90M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | $2.51M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.22M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $1.65M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.97M 10-Q · filed 2021-02-12 | |
| 2020-09-30 | $1.57M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $2.01M 10-K · filed 2021-09-28 | $2.01M 10-K · filed 2020-09-18 |
| 2020-03-31 | $1.09M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $750.75K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $1.13M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.74M 10-K · filed 2020-09-18 | |
| 2019-03-31 | $1.08M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.12M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $909.89K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.48M 10-K · filed 2019-09-09 | |
| 2018-03-31 | $1.89M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.83M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $1.44M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.18M 8-K · filed 2019-06-03 | |
| 2017-03-31 | $791.80K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $515.63K 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $405.84K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $584.00K 10-K · filed 2017-09-27 | |
| 2016-03-31 | $646.95K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $479.10K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $372.76K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $762.26K 10-K · filed 2016-09-13 | |
| 2015-03-31 | $486.18K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $256.53K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $293.99K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $244.91K 10-K · filed 2015-11-16 | |
| 2013-12-31 | $140.46K 10-K · filed 2014-08-28 | $249.49K 10-K · filed 2014-03-10 |
| 2012-12-31 | $677.62K 10-K · filed 2014-08-28 | $1.13M 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |